FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

386993000: Erythropoietin preparation (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1461171012 Erythropoietin preparation (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1481107019 Erythropoietin preparation en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Erythropoietin preparation Is a Hematologic agent (substance) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    erythropoietinpræparat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    allergi over for erythropoietin Causative agent False Erythropoietin preparation Inferred relationship Some
    Allergy to epoetin beta Causative agent False Erythropoietin preparation Inferred relationship Some
    overdosis af erythropoietin Causative agent False Erythropoietin preparation Inferred relationship Some
    Product containing epoetin beta (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 50.000 IE pulver og solvent til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 100.000 IE pulver og solvent til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 10.000 IE pulver og solvent til injektionsvæske, opløsning, cylinderampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 20.000 IE pulver og solvent til injektionsvæske, opløsning, cylinderampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 500 IE pulver og solvent til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 500 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 1000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 2000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 3000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 5000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 10.000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,6 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 60.000 IE pulver og solvent til injektionsvæske, opløsning, cylinderampul The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 6000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    epoetin beta 4000 IE injektionsvæske, opløsning i fyldt injektionssprøjte a 0,3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    Product containing darbepoetin alfa (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    darbepoetin alfa 25 µg/ml injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    darbepoetin alfa 40 µg/ml injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    darbepoetin alfa 60 µg/ml injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    darbepoetin alfa 100 µg/ml injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    darbepoetin alfa 200 µg/ml injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    Epoetin alfa (substance) Is a False Erythropoietin preparation Inferred relationship Some
    Darbepoetin alfa 150micrograms/0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    Darbepoetin alfa 100micrograms/0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    Darbepoetin alfa 80micrograms/0.4mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    Darbepoetin alfa 60micrograms/0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    Darbepoetin alfa 50micrograms/0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    Darbepoetin alfa 40micrograms/0.4mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    Darbepoetin alfa 30micrograms/0.3mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    Darbepoetin alfa 20micrograms/0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    Darbepoetin alfa 15micrograms/0.375mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some
    Darbepoetin alfa 10micrograms/0.4mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Erythropoietin preparation Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    SAME AS association reference set (foundation metadata concept)

    Back to Start